Development of Liposomal Combination Therapy to Target Cancer Stem Cells in Trastuzumab-Resistant HER2 Positive Breast Cancer

dc.contributor.advisor	Wu, Zimei
dc.contributor.advisor	Shelling, Andrew
dc.contributor.advisor	Leung, Euphemia
dc.contributor.author	Gao, Yu
dc.date.accessioned	2023-09-21T02:44:41Z
dc.date.available	2023-09-21T02:44:41Z
dc.date.issued	2023	en
dc.identifier.uri	https://hdl.handle.net/2292/65956
dc.description	Thesis embargoed until 09/2025.
dc.publisher	ResearchSpace@Auckland	en
dc.relation.ispartof	PhD Thesis - University of Auckland	en
dc.relation.isreferencedby	UoA	en
dc.rights	Restricted Item. Thesis embargoed until 9/2025. Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm	en
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/nz/
dc.title	Development of Liposomal Combination Therapy to Target Cancer Stem Cells in Trastuzumab-Resistant HER2 Positive Breast Cancer
dc.type	Thesis	en
thesis.degree.discipline	Pharmaceutics
thesis.degree.grantor	The University of Auckland	en
thesis.degree.level	Doctoral	en
thesis.degree.name	PhD	en
dc.date.updated	2023-09-14T01:04:03Z
dc.rights.holder	Copyright: The author	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/ClosedAccess	en

Files in this item